ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MEDG Medgenics(Regs)

302.50
0.00 (0.00%)
19 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Medgenics(Regs) LSE:MEDG London Ordinary Share COM SHS USD0.0001 (REGS)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 302.50 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Director/PDMR Shareholding

02/11/2009 12:30pm

UK Regulatory



 

TIDMMEDG 
 
RNS Number : 7769B 
Medgenics Inc 
02 November 2009 
 

Medgenics, Inc. 
('Medgenics' or the 'Company') 
 
 
2 November 2009 
 
 
The Board of Medgenics announces that on 30 October 2009 Mr. Joel Kanter (a 
Director of the Company) informed the Company that on 30 October he acquired in 
the market 25,000 common shares of par value US$ 0.0001 each ("Common Shares") 
in the Company at a price of 9.2 pence per Common Share. 
 
 
The total interest in Shares of Mr. Kanter and his related parties following 
this purchase is 14,078,397 Common Shares representing approximately 11.5 % of 
the issued share capital of the Company (excluding his interest in warrants, 
options and convertible debentures as previously announced). 
 
 
For further information, contact: 
 
 
+----------------------------------------------------+---------------------------------------+ 
| Medgenics, Inc.                                    | Phone: +972 4 902 8900                | 
| Dr. Andrew L. Pearlman                             |                                       | 
|                                                    |                                       | 
+----------------------------------------------------+---------------------------------------+ 
| Grayling (Financial PR, UK)                        | Phone: +44 7900 053 536               | 
| Jonathan Shillington                               | jonathan.shillington@uk.grayling.com  | 
| Alistair Scott                                     |                                       | 
|                                                    |                                       | 
+----------------------------------------------------+---------------------------------------+ 
| Blomfield Corporate Finance Limited (Nominated     | Phone: +44 207 444 0800               | 
| Adviser)                                           |                                       | 
| James Pinner                                       |                                       | 
| Alan MacKenzie                                     |                                       | 
|                                                    |                                       | 
+----------------------------------------------------+---------------------------------------+ 
| SVS Securities plc (Broker)                        | Phone: +44 207 638 5600               | 
| Ian Callaway                                       |                                       | 
|                                                    |                                       | 
+----------------------------------------------------+---------------------------------------+ 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RDSEAAFAEFPNFFE 
 

1 Year Medgenics(Regs) Chart

1 Year Medgenics(Regs) Chart

1 Month Medgenics(Regs) Chart

1 Month Medgenics(Regs) Chart